Preventing COVID-19-induced pneumonia with anticytokine therapy

Affiliations

¹ Department of Systems Medicine, University of Rome Tor Vergata, 00133 Rome, Italy.
² Rheumatology Unit, ASST Fatebenefratelli Sacco-Department of Biochemical and Clinical Sciences "L Sacco", University of Milan, Milan, Italy.
³ Gastrointestinal Unit, ASST Fatebenefratelli Sacco-Department of Biochemical and Clinical Sciences "L Sacco", University of Milan, Milan, Italy.

Giovanni Monteleone et al. Lancet Rheumatol. 2020 May.

. 2020 May;2(5):e255-e256.

doi: 10.1016/S2665-9913(20)30092-8. Epub 2020 Apr 6.

¹ Department of Systems Medicine, University of Rome Tor Vergata, 00133 Rome, Italy.
² Rheumatology Unit, ASST Fatebenefratelli Sacco-Department of Biochemical and Clinical Sciences "L Sacco", University of Milan, Milan, Italy.
³ Gastrointestinal Unit, ASST Fatebenefratelli Sacco-Department of Biochemical and Clinical Sciences "L Sacco", University of Milan, Milan, Italy.

No abstract available

References

1. El-Gabalawy H, Guenther LC, Bernstein CN. Epidemiology of immune-mediated inflammatory diseases: incidence, prevalence, natural history, and comorbidities. J Rheumatol Suppl. 2010;85(suppl 85):2–10. - PubMed
1. Dulai PS, Thompson KD, Blunt HB, Dubinsky MC, Siegel CA. Risks of serious infection or lymphoma with anti-tumor necrosis factor therapy for pediatric inflammatory bowel disease: a systematic review. Clin Gastroenterol Hepatol. 2014;12:1443–1451. - PubMed
1. Zhu N, Zhang D, Wang W. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med. 2020;382:727–733. - PMC - PubMed
1. Chen C, Zhang XR, Ju ZY, He WF. Advances in the research of cytokine storm mechanism induced by corona virus disease 2019 and the corresponding immunotherapies. Zhonghua Shao Shang Za Zhi. 2020;36:e005. [in Chinese]. - PubMed
1. Tanaka T, Narazaki M, Kishimoto T. Immunotherapeutic implications of IL-6 blockade for cytokine storm. Immunotherapy. 2016;8:959–970. - PubMed